Yutaka Kawahito Selected Research

Yutaka Kawahito Research Topics

Disease

31	Rheumatoid Arthritis 08/2022 - 01/2005
19	Neoplasms (Cancer) 03/2010 - 05/2002
10	Inflammation (Inflammations) 12/2021 - 01/2005
8	Renal Cell Carcinoma (Grawitz Tumor) 03/2010 - 12/2003
7	Arthritis (Polyarthritis) 01/2019 - 08/2004
7	Prostatic Neoplasms (Prostate Cancer) 03/2010 - 05/2002
6	Fibrosis (Cirrhosis) 10/2021 - 05/2007
5	Testicular Neoplasms (Testicular Cancer) 03/2010 - 09/2002
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2010 - 05/2003
5	Urologic Neoplasms (Urological Cancer) 03/2010 - 12/2003
4	Infections 02/2022 - 11/2020
4	Reperfusion Injury 03/2010 - 07/2008
4	Carcinogenesis 04/2009 - 07/2007
3	Rheumatic Diseases (Rheumatism) 11/2020 - 11/2016
3	Experimental Arthritis 01/2019 - 10/2005
3	Osteoporosis 11/2016 - 01/2008
3	Ischemia 07/2008 - 07/2008
3	Neoplasm Metastasis (Metastasis) 01/2004 - 06/2003
3	Carcinoma (Carcinomatosis) 12/2003 - 05/2003
2	Surgical Wound Infection 02/2022 - 09/2015
2	Pain (Aches) 01/2022 - 07/2013
2	Pneumonia (Pneumonitis) 12/2021 - 01/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2018 - 11/2014
2	Connective Tissue Diseases (Connective Tissue Disease) 11/2016 - 05/2007
2	Bone Resorption 11/2016 - 01/2008
2	Osteoarthritis 11/2015 - 05/2008
2	Lupus Nephritis 11/2014 - 01/2008
2	Cachexia 10/2010 - 01/2005
2	Stomach Neoplasms (Stomach Cancer) 06/2003 - 05/2002
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 08/2022
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2022
1	Rhinitis 07/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2022
1	Diabetes Mellitus 02/2022
1	COVID-19 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Thumb deformity 01/2021
1	Nutrition Disorders (Nutritional Disorders) 01/2021
1	Chronic Hepatitis C 11/2020
1	Oral Candidiasis (Thrush) 01/2020
1	Hypoalbuminemia 01/2020
1	Immune System Diseases (Immune Disorders) 01/2019
1	Synovitis 09/2018
1	Osteitis 09/2018

Drug/Important Bio-Agent (IBA)

13	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2009 - 11/2003
11	Arachidonic Acid (Vitamin F)IBA 04/2009 - 11/2003
11	Lipoxygenase (Lipoxygenase-1)IBA 04/2009 - 11/2003
8	Biological ProductsIBA 02/2022 - 09/2015
7	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2003
7	LigandsIBA 03/2010 - 05/2002
6	Antirheumatic Agents (DMARD)IBA 02/2022 - 09/2015
6	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021 - 05/2007
6	CytokinesIBA 01/2019 - 01/2005
6	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2007
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2010 - 05/2002
5	Abatacept (Orencia)FDA Link 05/2019 - 08/2012
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2005
5	EicosanoidsIBA 07/2008 - 11/2003
4	Pharmaceutical PreparationsIBA 07/2022 - 01/2005
4	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 03/2010 - 07/2007
4	PPAR gammaIBA 12/2003 - 05/2002
3	GlucocorticoidsIBA 08/2022 - 01/2016
3	CollagenIBA 01/2019 - 05/2007
3	Prednisolone (Predate)FDA LinkGeneric 11/2016 - 07/2007
3	Small Interfering RNA (siRNA)IBA 11/2015 - 10/2005
3	Telmisartan (Micardis)FDA Link 03/2010 - 08/2008
3	Lipoxygenase InhibitorsIBA 07/2005 - 11/2003
2	Therapeutic UsesIBA 10/2021 - 11/2015
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 01/2014
2	indium-bleomycinIBA 01/2018 - 01/2014
2	Diphosphonates (Bisphosphonates)IBA 11/2016 - 01/2016
2	Infliximab (Remicade)FDA Link 06/2016 - 06/2007
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2014
2	MucinsIBA 03/2011 - 03/2003
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2008 - 03/2006
2	ProstaglandinsIBA 01/2008 - 03/2003
2	mizoribineIBA 01/2008 - 07/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2007 - 12/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2004 - 04/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2004 - 03/2003
2	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2004 - 11/2003
2	PPAR alphaIBA 05/2003 - 09/2002
1	Biosimilar PharmaceuticalsIBA 01/2022
1	titanium dioxide (Titania)FDA Link 12/2021
1	C-Reactive ProteinIBA 01/2021
1	Particulate MatterIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	InterferonsIBA 11/2020
1	Antiviral Agents (Antivirals)IBA 11/2020
1	Serum AlbuminIBA 01/2020
1	AntibodiesIBA 01/2019

Therapy/Procedure

11	Therapeutics 02/2022 - 06/2004
2	Orthopedic Procedures 02/2022 - 09/2015
1	Operative Time 02/2022
1	Exercise Therapy (Therapy, Exercise) 01/2022
1	Replacement Arthroplasty 01/2022
1	Drug Therapy (Chemotherapy) 01/2021